Therapeutic drug monitoring with tricyclic antidepressants: a response
Preskorn, S.H.
Journal of Clinical Psychopharmacology 14(4): 277-278
1994
ISSN/ISBN: 0271-0749 PMID: 7962685 Document Number: 424619
Document emailed within 1 workday
Related Documents
Dixon, R.; Marin, D. 1981: Tricyclic antidepressants: a simplified approach for the routine clinical monitoring of parent drug and metabolites in plasma using HPLC Research Communications in Chemical Pathology and Pharmacology 33(3): 537-545Pentel, P.R.; Keyler, D.E.; Brunn, G.J.; Milavetz, J.M.; Gilbertson, D.G.; Matta, S.G.; Pond, S.M. 1991: Redistribution of tricyclic antidepressants in rats using a drug-specific monoclonal antibody: dose-response relationship Drug Metabolism and Disposition: the Biological Fate of Chemicals 19(1): 24-28
Laux, G.; Baumann, P.; Hiemke, C. 2007: Therapeutic drug monitoring of antidepressants--clinical aspects Journal of Neural Transmission. Supplementum 72: 261-267
Grzesiak, M.; Beszłej, J.A.; Szewczuk-Bogusławska, M. 2003: Therapeutic monitoring of tricyclic antidepressant drugs Psychiatria Polska 37(5): 825-837
Frewin, D.B.; Shaw, D.R.; Bochner, F. 1982: Therapeutic drug monitoring: a survey of sub- and supra-therapeutic serum drug levels in a large teaching hospital New Zealand Medical Journal 95(719): 774-776
Sjöqvist, F. 1980: The measurement of psychotherapeutic drug concentrations in biological fluids: utility in clinical trials and practice. Overview by drug classes--clinical monitoring of tricyclic antidepressant plasma concentrations Psychopharmacology Bulletin 16(3): 21-25
Spiker, D.G. 1978: The toxicity of tricyclic antidepressants Communications in Psychopharmacology 2(5): 419-427
1993: Tricyclic antidepressants: advantages and limitations Geriatrics 48 Suppl. 2: 6-8
Gwynne, J.F. 1971: Tricyclic antidepressants and heart disease New Zealand Medical Journal 74(475): 414-415
Jackson, W.K.; Roose, S.P.; Glassman, A.H. 1987: Cardiovascular toxicity and tricyclic antidepressants Biomedicine and PharmacoTherapy 41(7): 377-382
Chodorowski, Z.; Anand, J.S. 1999: Suicidal poisoning with tricyclic antidepressants Przeglad Lekarski 56(6): 438-441
Small, G.W. 1989: Tricyclic antidepressants for medically ill geriatric patients Journal of Clinical Psychiatry 50 Suppl: 27-31; Discussion: 32-33
Braithwaite, R.A. 1980: Plasma-protein binding of tricyclic antidepressants Postgraduate Medical Journal 56(Suppl 1): 107-111
Judd, F.; Boyce, P. 1999: Tricyclic antidepressants in the treatment of depression. do they still have a place? Australian Family Physician 28(8): 809-813
Oksenkrug, G.F.; Lapin, I.P. 1972: Differentiation of secondary and tertiary tricyclic antidepressants in frogs Biulleten' Eksperimental'noi Biologii i Meditsiny 73(7): 64-66
Márquez del Cid, J.; Vergara Chozas, J.M.; Crespo, S.; Meca Rovayo, M.L. 1991: The efficacy of hemoperfusion in acute poisoning by tricyclic antidepressants Medicina Clinica 97(14): 555
2003: Older tricyclic antidepressants were potent suicide-agents Lakartidningen 100(18): 1651-1652
Syrek, M.; Wójcikowski, J.; Daniel, W.A. 1997: Promazine pharmacokinetics during concurrent treatment with tricyclic antidepressants Polish Journal of Pharmacology 49(6): 453-462
Glassman, A.H.; Walsh, B.T.; Roose, S.P.; Rosenfeld, R.; Bruno, R.L.; Bigger, J.T.; Giardina, E.G. 1982: Factors related to orthostatic hypotension associated with tricyclic antidepressants Journal of Clinical Psychiatry 43(5 Part 2): 35-38
Brunswick, D.J.; Mendels, J. 1977: Reduced levels of tricyclic antidepressants in plasma from Vacutainers Communications in Psychopharmacology 1(2): 131-134